Primary pharyngolaryngectomy with jejunal free flap reconstruction: a single centre's evolving experience.

head and neck cancer hypopharyngeal cancer otolaryngology head and neck surgery pharyngolaryngectomy squamous cell carcinoma surgical oncology

Journal

ANZ journal of surgery
ISSN: 1445-2197
Titre abrégé: ANZ J Surg
Pays: Australia
ID NLM: 101086634

Informations de publication

Date de publication:
10 2020
Historique:
received: 24 09 2019
revised: 25 03 2020
accepted: 09 04 2020
pubmed: 2 5 2020
medline: 30 4 2021
entrez: 2 5 2020
Statut: ppublish

Résumé

Head and neck squamous cell carcinoma, and in particular hypopharyngeal squamous cell carcinoma, has long been associated with disfiguring treatment options, significant morbidity and limited long-term survival outcomes. Total pharyngolaryngectomy (TPL) with free flap reconstruction followed by post-operative radiation therapy or chemoradiotherapy is a widely accepted treatment of choice for advanced disease of the hypopharynx. Our unit undertook a 11-year review of all primary TPL patients aiming to provide an update on survival outcomes, morbidity, post-operative complications and evolving management strategies. We report one of the largest single-centre series to date with 89 patients undergoing primary TPL between 2003 and 2013, and compare these outcomes to 180 patients undergoing TPL at the same facility in the previous 23 years. Between study periods, we saw a shift in patient population towards higher stage disease (T-stage 3 or 4 97% 2003-2013; 68% 1979-2002) and increased nodal involvement (node positive 88% 2003-2013; 70% 1979-2002) without a subsequent reduction in 5-year disease-specific survival (52% 2003-2013; 52% 1979-2002) or 5-year overall survival (32% 2003-2013; 33% 1979-2002).

Sections du résumé

BACKGROUND
Head and neck squamous cell carcinoma, and in particular hypopharyngeal squamous cell carcinoma, has long been associated with disfiguring treatment options, significant morbidity and limited long-term survival outcomes. Total pharyngolaryngectomy (TPL) with free flap reconstruction followed by post-operative radiation therapy or chemoradiotherapy is a widely accepted treatment of choice for advanced disease of the hypopharynx.
METHODS
Our unit undertook a 11-year review of all primary TPL patients aiming to provide an update on survival outcomes, morbidity, post-operative complications and evolving management strategies. We report one of the largest single-centre series to date with 89 patients undergoing primary TPL between 2003 and 2013, and compare these outcomes to 180 patients undergoing TPL at the same facility in the previous 23 years.
RESULTS
Between study periods, we saw a shift in patient population towards higher stage disease (T-stage 3 or 4 97% 2003-2013; 68% 1979-2002) and increased nodal involvement (node positive 88% 2003-2013; 70% 1979-2002) without a subsequent reduction in 5-year disease-specific survival (52% 2003-2013; 52% 1979-2002) or 5-year overall survival (32% 2003-2013; 33% 1979-2002).

Identifiants

pubmed: 32356604
doi: 10.1111/ans.15930
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1965-1969

Informations de copyright

© 2020 Royal Australasian College of Surgeons.

Références

Patel RS, Goldstein DP, Brown D et al. Circumferential pharyngeal reconstruction: history, critical analysis of techniques, and current therapeutic recommendations. Head Neck 2009; 32: 109-20.
Takes RP, Strojan P, Silver CE et al. Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck 2012; 34: 270-81.
Perez-Smith D, Wagels M, Theile DR. Jejunal free flap reconstruction of the pharyngolaryngectomy defect: 368 consecutive cases. Br. J. Plast. Surg. 2013; 66: 9-15.
Chu P-Y, Chang S-Y. Reconstruction of the hypopharynx after surgical treatment of squamous cell carcinoma. J. Chin. Med. Assoc. 2009; 72: 351-5.
Bova R, Goh R, Poulson M, Coman W. Total pharyngolaryngectomy for squamous cell carcinoma of the hypopharynx: a review. Laryngoscope 2005; 115: 864-9.
Kim S-Y, Rho Y-S, Choi E-C et al. Clinicopathological factors influencing the outcomes of surgical treatment in patients with T4a hypopharyngeal cancer. BMC Cancer 2017; 17: 1-7.
Nouraei SAR, Dias A, Kanona H et al. Impact of the method and success of pharyngeal reconstruction on the outcome of treating laryngeal and hypopharyngeal cancers with pharyngolaryngectomy: a national analysis. Br. J. Plast. Surg. 2017; 70: 628-38.
Theile DR, Robinson DW, Theile DE, Coman WB. Free jejunal interposition reconstruction after pharyngolaryngectomy: 201 consecutive cases. Head Neck 1995; 17: 83-8.
Garneau JC, Bakst RL, Miles BA. Oral oncology. Oral Oncol. 2018; 86: 244-50.
Newman JR, Connolly TM, Illing EA, Kilgore ML, Locher JL, Carrol WR. Survival trends in hypopharyngeal cancer: a population-based review. Laryngoscope 2014; 125: 624-9.
Kim S, Wu HG, Heo DS, Kim KH, Sung MW, Park CI. Advanced hypopharyngeal carcinoma treatment results according to treatment modalities. Head Neck 2001; 23: 713-7.
Eckel HE, Staar S, Volling P, Sittel C, Damm M, Jungehuelsing M. Surgical treatment for hypopharynx carcinoma: feasibility, mortality, and results. Otolaryngol. Head Neck Surg. 2016; 124: 561-9.
Petersen JF. Trends in treatment, incidence and survival of hypopharynx cancer: a 20-year population-based study in the Netherlands. Eur. Arch. Otorhinolaryngol. 2017; 275: 181-9.
Harris BN, Biron VL, Donald P et al. Primary surgery vs. chemoradiation treatment of advanced-stage hypopharyngeal squamous cell carcinoma. JAMA Otolaryngol. Head Neck Surg. 2015; 141: 636-40.
Atienza JAS, Dasanu CA. Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature. Curr. Med. Res. Opin. 2012; 28: 1899-909.
Chu P-Y, Chang S-Y, Huang J-L, Tai S-K. Different patterns of second primary malignancy in patients with squamous cell carcinoma of larynx and hypopharynx. Am. J. Otolaryngol. 2010; 31: 168-74.
Razdan S, Albornoz C, Matros E, Paty P, Cordeiro P. Free jejunal flap for pharyngoesophageal reconstruction in head and neck cancer patients: an evaluation of donor-site complications. J. Reconstr. Microsurg. 2015; 31: 643-6.
Mura F, Bertino G, Occhini A, Mevio N, Scelsi D, Benazzo M. Advanced carcinoma of the hypopharynx: functional results after circumferential pharyngolaryngectomy with flap reconstruction. Acta Otorhinolaryngol. Ital. 2012; 32: 154-7.
López F, Obeso S, Camporro D, Fueyo A, Suarez C, Llorente JL. Outcomes following pharyngolaryngectomy with fasciocutaneous free flap reconstruction and salivary bypass tube. Laryngoscope 2012; 123: 591-6.
Ho MW, Houghton L, Gillmartin E et al. Outcomes following pharyngolaryngectomy reconstruction with the anterolateral thigh (ALT) free flap. Br. J. Oral Maxillofac. Surg. 2012; 50: 19-24.
Ward EC, Bishop B, Frisby J, Stevens M. Swallowing outcomes following laryngectomy and pharyngolaryngectomy. Arch. Otolaryngol. Head Neck Surg. 2002; 128: 181-6.
Murray DJ, Novak CB, Neligan PC. Fasciocutaneous free flaps in pharyngolaryngo-oesophageal reconstruction: a critical review of the literature. J. Plast. Reconstr. Aesthet. Surg. 2008; 61: 1148-56.

Auteurs

Courtenay Henrys (C)

Department of Otolaryngology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

Thomas Slaughter (T)

Department of Otolaryngology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

Anne Bernard (A)

Department of Otolaryngology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

Christopher Perry (C)

Department of Otolaryngology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

Sandro Porceddu (S)

Department of Otolaryngology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

Benedict Panizza (B)

Department of Otolaryngology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH